Immune Response News and Research

RSS

Significant advance in the understanding of the hepatitis C virus (HCV)

Researchers have made a significant advance in the understanding of the hepatitis C virus (HCV) by identifying new genetic factors associated with clearing the virus spontaneously without the necessity for additional treatment.

9 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

Experimental vaccine against ricin

Scientists have developed an experimental vaccine against ricin, a potential biological threat agent, which fully protected mice from aerosol challenge with lethal doses of the toxin.

5 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

Proof of principle that it is possible to deliver new genes body-wide to all the muscles of an adult animal

MDA-supported researchers at the University of Washington-Seattle have delivered the gene for the dystrophin protein to all voluntary muscles with a single intravenous injection in mice with Duchenne muscular dystrophy (DMD).

29 Jul 2004

Researchers discover a carbohydrate with an unusual structure in the cell walls of the bacterium that causes tuberculosis

Even though we have lost much of our fear of tuberculosis in the industrialized countries, according to the WHO about 2 million people worldwide die each year of this infectious disease.

28 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Russian scientists incorporate HIV antigen into a tomato

Russian scientists are currently creating a pleasant and harmless vaccine, and edible one at that. So far, they managed to incorporate the protein gene – HIV antigen in tomatoes. The research is supported by International Science and Technology Center.

19 Jul 2004

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

Research team developing new defenses against plague and smallpox

Using a federal biodefense grant, a Wake Forest University Baptist Medical Center team will try to develop new approaches to immunizing people against the plague and smallpox, two of the most feared potential agents of bio-terrorism.

15 Jul 2004

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to two articles in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Important milestone for any cancer therapy that will be useful for treating patients

Mayo Clinic researchers have manipulated a human antibody to induce an anti-tumor response in living mice that consistently curbs - and often cures - malignant melanoma, one of the most lethal forms of skin cancer and the most common cancer of young adults.

15 Jul 2004

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

At the XVth International AIDS Conference in Bangkok, Thailand, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases and chief of the NIAID Laboratory of Immunoregulation (LIR), will present his laboratory’s latest findings on how aberrant immune activation underlies HIV pathogenesis.

15 Jul 2004

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Scientists affiliated with the Harvard University Medical School have devised ways of bolstering patients' immune response against kidney and breast cancer.

15 Jul 2004

Genetic mutation is a major contributor to type 1 diabetes

A natural mutation of a gene that helps regulate the reactivity of the immune system is a major contributor to type 1 diabetes, Medical College of Georgia researchers have found.

12 Jul 2004

Chromatin array a new technology for examining DNA

A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease.

8 Jul 2004

Type of cellular stress called osmotic stress is critical to cell growth and the body’s immune response against infection

Researchers at the University of California, San Diego (UCSD) School of Medicine have determined that a particular type of cellular stress called osmotic stress is of critical importance to cell growth and the body’s immune response against infection.

7 Jul 2004

Stress alters immunity

Psychologists have long known that stress affects our ability to fight infection, but a major new “meta-analysis” – a study of studies – has elucidated intriguing patterns of how stress affects human immunity, strengthening it in the short term but wearing it down over time.

2 Jul 2004

Protein called Rac controls a number of biological processes and is directly implicated in several human diseases

Scientists at The Scripps Research Institute have described the regulatory mechanism of an important human protein called Rac that controls a number of biological processes and is directly implicated in several human diseases.

2 Jul 2004

Celiac disease may affect 3 million Americans, ten times higher than previous estimates

Celiac disease is considerably under-diagnosed, according to an independent consensus panel convened this week by the National Institutes of Health (NIH).

1 Jul 2004

Immune Response News and Research

Significant advance in the understanding of the hepatitis C virus (HCV)

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

Experimental vaccine against ricin

New approach to cancer vaccines may eradicate skin cancer tumors

Proof of principle that it is possible to deliver new genes body-wide to all the muscles of an adult animal

Researchers discover a carbohydrate with an unusual structure in the cell walls of the bacterium that causes tuberculosis

A new vaccine that may delay cancer recurrence

Russian scientists incorporate HIV antigen into a tomato

3M granted FDA approval for cream to treat superficial basal cell carcinoma

Research team developing new defenses against plague and smallpox

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Important milestone for any cancer therapy that will be useful for treating patients

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Genetic mutation is a major contributor to type 1 diabetes

Chromatin array a new technology for examining DNA

Type of cellular stress called osmotic stress is critical to cell growth and the body’s immune response against infection

Stress alters immunity

Protein called Rac controls a number of biological processes and is directly implicated in several human diseases

Celiac disease may affect 3 million Americans, ten times higher than previous estimates

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News